Table 3. Factors Associated With Receipt of All Four Beneficial Cardiac Medications in Men According to Age (years).

Clinical Characteristics	<65		65-74		75-84		≥85
	O.R.	95% CI	O.R.	95% CI	O.R.	95% CI	O.R.	95% CI
Comorbid conditions
0-1	0.55	0.36,0.83	0.53	0.32,0.86	0.49	0.30,0.79	1.04	0.46,2.37
2	0.55	0.37,0.82	1.05	0.68,1.63	0.69	0.45,1.05	1.03	0.48,2.24
Acute myocardial infarction characteristics
Initial	0.82	0.58,1.15	1.03	0.69,1.55	1.11	0.76,1.64	1.65	0.82,3.32
Q wave	1.41	1.11,1.78	0.96	0.67,1.37	0.89	0.57,1.39	0.74	0.30,1.87
Clinical complications
Heart failure	0.91	0.67,1.25	0.96	0.68,1.36	0.93	0.66,1.32	0.74	0.40,1.37
Cardiogenic shock	1.41	0.77,2.57	1.73	0.83,3.59	1.27	0.57,2.83	6.26	0.68,57.65
Atrial fibrillation	0.73	0.47,1.13	0.91	0.62,1.34	0.73	0.51,1.06	1.18	0.61,2.30
Discharged alive	5.33	1.98,14.35	2.04	0.91,4.55	1.69	0.87,3.28	4.38	1.37,14.04
Revascularization procedures	3.88	2.84,5.29	2.48	1.75,3.51	2.57	1.81,3.64	8.20	4.23,15.89

^*Referent categories: presence of ≥3 comorbidities, prior acute myocardial infarction, non-Q wave acute myocardial infarction, absence of selected hospital clinical complications, dead at discharge, and lack of receipt of revascularization procedures